Acknowledgements

This study was funded by Boehringer Ingelheim Pharmaceuticals, Inc (BIPI). Editorial and formatting assistance was provided by Elizabeth Ng and Wendy Morris of FleishmanHillard Fishburn, which was contracted and funded by BIPI. The authors meet criteria for authorship as recommended by the International Committee of Medical Journal Editors (ICMJE), received no direct compensation for the development of the poster, were fully responsible for all content and editorial decisions, were involved at all stages of development and have approved the final version. BI was given the opportunity to review the poster for medical and scientific accuracy as well as intellectual property considerations. Todd L. Astor is a consultant to Qx Therapeutics. Peter LaCamera reports no disclosures. Howard M Lazarus was an employee of BIPI at the time that this study was conducted.